Work

Phase II study of ecteinascidin 743 in heavily pretreated patients with recurrent osteosarcoma

Year: 2003

Type: article

Study design: Clinical Trial

Source: Cancer

DOI: 10.1002/cncr.11563

Authors: Caroline Laverdiere, E. Anders Kolb, Jeffrey G. Supko, Richard Gorlick, Paul A. Meyers, Robert G. Maki, Leonard Wexler, George D. Demetri, John H. Healey, Andrew G. Huvos, Allen M. Goorin, Rochelle Bagatell, Ana Ruiz‐Casado, Cecilia Guzman, Jose Jimeno, David Harmon

Institutions: Memorial Sloan Kettering Cancer Center, Harvard University, Dana-Farber/Harvard Cancer Center, University of Arizona, PharmaMar (Spain)

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Award: Soft Tissue Sarcoma Program Project

OpenAlex ID: W2063654089

FWCI: 6.754

Cites: 49

Cited by: 97

Related to: 10